NCT02199236 2024-11-01Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative ManagementMemorial Sloan Kettering Cancer CenterPhase 1 Completed15 enrolled